Drug shortages could present national security risk to U.S., report says

Vials of medication in a stock photo.
(Image credit: Stock Photo via Getty Images)

Shortages of critical drugs could represent an ongoing national security risk to the United States, a new report said Wednesday.

The report, helmed by the Senate Homeland Security and Governmental Affairs Committee, found that drug shortages across the country increased nearly 30 percent from 2021 to 2022. These shortages have been caused by a variety of factors, including supply chain issues and economic swings, the report said.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

These risks are based on the fact that 90 to 95 percent of generic sterile injectable drugs are dependent on base materials from China and India, the report said. Peters said that this reliance on foreign drug suppliers "remains an unacceptable national security risk."

However, this extreme shortage of drugs is not a new phenomenon. The report noted that at least 15 critical care drugs have been in shortened supply for more than a decade. This includes medications used to treat a variety of ailments from cancer to asthma, the report said.

Erin Fox, a pharmacist and professor at the University of Utah College of Pharmacy who has been tracking drug shortages for more than 20 years, told ABC News that because of the shortages, "patients and hospitals routinely cannot access the most basic and essential prescription medications."

Fox told ABC she is planning to testify at the hearing, where she "plans to describe the challenges of providing medical care in an environment where shortages are commonplace, citing studies that show adverse patient outcomes when providers are faced with shortages."

Justin Klawans, The Week US

Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and other news. Justin has also freelanced for outlets including Collider and United Press International.